Panel on Retinoblastoma Treatment Guidelines and New Treatments at One Retinoblastoma World 2020 Conference held virtually on October 3 & 4, 2020.
Hosted by World Eye Cancer Hope, International Retinoblastoma Consortium, Canadian Retinoblastoma Research Advisory Board, and Canadian Retinoblastoma Society.
For more information visit: [ Ссылка ]

Katherine E. Paton, MD FRCSC, Clinical Professor, Head of Ocular Oncology and Medical Director Diagnostic Ultrasound, University of British Columbia, Vancouver, Canada; Head of Comprehensive Ophthalmology, Vancouver Coastal Health Authority, Vancouver, Canada; Tumour Group Chair, Ocular & Orbital Site, British Columbia Cancer Agency, Vancouver, Canada.
Leslie G. Low, Member, Canadian Retinoblastoma Research Advisory Board; Parent of Retinoblastoma Survivors, Edmonton, Canada.
Brenda L. Gallie, MD, FRCSC, Ophthalmologist & Director, Retinoblastoma Program, The Hospital for Sick Children (SickKids), Toronto, Canada; Professor, University of Toronto, Toronto, Canada; Founder, International Retinoblastoma Consortium; Co-founder, World Eye Cancer Hope.
Vera A. Essuman, MBChB, Senior Lecturer & Head of Ophthalmology, College of Health Sciences School of Medicine and Dentistry Department of Surgery, University of Ghana, Accra, Ghana; Pediatric Ophthalmologist/Ophthalmic Surgeon, Korle-Bu Teaching Hospital, Accra, Ghana.

With timely screening, diagnosis, referral, treatment, and follow-up delivered in a systematic way by a multidisciplinary team, most children with retinoblastoma are cured, many with useful vision. Yet many families everywhere do not receive optimal care. This session will provide an overview of what treatment guidelines are and how they can help in low-, middle-, and high-income countries as well as new developments in retinoblastoma treatment options. Both implementation of proven therapy and testing of new therapies in any setting will be discussed, with a focus on intra-arterial chemotherapy and the sustained-release topotecan episcleral plaque.

свернуть